Photo

Photo detail

Stories this photo appears in:

Avelas Closes $6.85M Series B Financing Round, Names New CEO

Avelas Biosciences Inc. announced it closed on a $6.85 million Series B financing round, and has also promoted chief business officer Carmine Stengone to the role of CEO.

Tease photo